Next Article in Journal
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models
Next Article in Special Issue
Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy
Previous Article in Journal
A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model
Previous Article in Special Issue
Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 88; https://doi.org/10.3390/pharmaceutics14010088
Action Date Notes Link
article xml file uploaded 30 December 2021 14:03 CET Original file -
article xml uploaded. 30 December 2021 14:03 CET Update -
article pdf uploaded. 30 December 2021 14:03 CET Version of Record -
article html file updated 30 December 2021 14:05 CET Original file -
article xml file uploaded 30 December 2021 15:11 CET Update -
article xml uploaded. 30 December 2021 15:11 CET Update https://www.mdpi.com/1999-4923/14/1/88/xml
article pdf uploaded. 30 December 2021 15:11 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/88/pdf
article html file updated 30 December 2021 15:13 CET Update -
article html file updated 31 July 2022 01:20 CEST Update https://www.mdpi.com/1999-4923/14/1/88/html
Back to TopTop